Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Chiropractor Dr. Rajneesh Kant was honoured with the Asia Book of Records  in Dubai ( 29 June) and world book of records in London 18th July National
  • Shalby Hospital Surat Launches Advanced Interventional Pulmonology Department for South Gujarat Health
  • Aaiji Group Elevates Dholera SIR’s Real Estate Landscape with Innovative Developments Business
  • Gandhinagar: 16-year-old Bhavika Maheshwari Becomes Brand Ambassador of Children’s Research University Education
  • HOAC Foods India Limited’s QIP open on June 30, 2025 Business
  • Vikas Lifecare to launch a Rs 200 crore QIP, company to raise Rs 50 cr in 1st tranche Business
  • Hindu Research Foundation Honors Seven Eminent Personalities in Nagpur Lifestyle
  • IIT Bombay and Washington University in St. Louis invite applications for their 9th Batch of executive MBA program Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Sunpure receives patent for Curcuminoids Complex AKTIV C5 (CURCUBOOST®) Health
  • Hairsncares: Revolutionizing Hair Health with a Holistic Digital Approach Health
  • Dr. Sadiya Unveils The 5C Approach in Lifestyle Prescriptions for Diabetes and Prediabetes Health
  • The Top 5 Nutrients Men Often Lack in Their Diet Health
  • IPCA Laboratories Ltd launches Diulcus® to address Diabetic Foot Ulcer in India Health
  • Krishna’s Ayurveda Diabic Care Juice Clinically Proven to Reduce Blood Sugar Levels in 12 Weeks Health

Recent Posts

  • Kore Digital Enters India’s Defense Manufacturing Ecosystem with Indian Air Force Vendor Approval
  • Prikansha Luthra and the Emerging Voice of Women in India’s Defence Manufacturing Ecosystem
  • Yuvarambh 2026: Building Real Pathways for Youth Entrepreneurship
  • Hipmunk Returns to Simplify the Flight Booking Experience
  • Best Crypto Presales Include MAXI and PEPA, but DeepSnitch AI Looks Harder to Ignore With Stage 7 Live and Uniswap Listing Announced

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Chennai-based Whoa Mama Design creates a piping hot opening sequence for Koffee with Karan Entertainment
  • Sabyasachi Crowned World Champion of Public Speaking in Philadelphia Lifestyle
  • Eat Like You Mean It: Why 2026’s Food Trends Feel Less Like Fashion And More Like Personality Lifestyle
  • Designing Tomorrow: How JAIN’s BSc Interior Design Is Shaping the Next Generation of Spatial Innovators Education
  • Vegandukan Is Launching Its New Range of Products Including Vegan Ready-to-eat Desi Khana Business
  • OneEarth Foundation’s Triumph over Plastic Pollution in Goa National
  • Top 5 Inspiring Business Titans of 2023 Business
  • Dr. Harish Yadav – A Multi-Talented Indian Government Official with a Flair for Creativity Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme